Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study yesterday.
Presenting the findings at the European Society of Cardiology’s annual meeting in London, they said the study showed for the first time that blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the following three decades.
“This is good for patients first and foremost, but it is also important information for [manufacturers of] cholesterol lowering drugs, anti-inflammatory drugs and lipoprotein(a)-lowering drugs — the implications for therapy are broad,” said Paul Ridker of Brigham and Women’s Hospital in Boston, the study leader.
Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data ... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of five or 10 year risk.”
The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low-density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.
They also had tests for high-sensitivity C-reactive protein (hsCRP) — a marker of blood vessel inflammation — and lipoprotein(a), a genetically determined type of fat.
Compared with risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the following 30 years were 36 percent higher in women with the highest levels of LDL-C, 70 percent higher in women with the highest levels of hsCRP and 33 percent higher in those with the highest levels of lipoprotein(a).
Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the following three decades, said a report of the study in The New England Journal of Medicine that was published to coincide with the presentation at the meeting.
“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said. “The therapies we might use in response to an elevation in each biomarker are markedly different and physicians can now specifically target the individual person’s biologic problem.”
While drugs that lower LDL-C and hsCRP are widely available — including statins, and pills for high blood pressure and heart failure — drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis, Amgen, Eli Lilly and London-based Silence Therapeutics.
Lifestyle changes such as exercising and quitting smoking can also be helpful.
Most of the women in the study were white Americans, but the findings would likely “have even greater impact among black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.
“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”
CONDITIONS: The Russian president said a deal that was scuppered by ‘elites’ in the US and Europe should be revived, as Ukraine was generally satisfied with it Russian President Vladimir Putin yesterday said that he was ready for talks with Ukraine, after having previously rebuffed the idea of negotiations while Kyiv’s offensive into the Kursk region was ongoing. Ukraine last month launched a cross-border incursion into Russia’s Kursk region, sending thousands of troops across the border and seizing several villages. Putin said shortly after there could be no talk of negotiations. Speaking at a question and answer session at Russia’s Eastern Economic Forum in Vladivostok, Putin said that Russia was ready for talks, but on the basis of an aborted deal between Moscow’s and Kyiv’s negotiators reached in Istanbul, Turkey,
In months, Lo Yuet-ping would bid farewell to a centuries-old village he has called home in Hong Kong for more than seven decades. The Cha Kwo Ling village in east Kowloon is filled with small houses built from metal sheets and stones, as well as old granite buildings, contrasting sharply with the high-rise structures that dominate much of the Asian financial hub. Lo, 72, has spent his entire life here and is among an estimated 860 households required to move under a government redevelopment plan. He said he would miss the rich history, unique culture and warm interpersonal kindness that defined life in
A French woman whose husband has admitted to enlisting dozens of strangers to rape her while she was drugged on Thursday told his trial that police had saved her life by uncovering the crimes. “The police saved my life by investigating Mister Pelicot’s computer,” Gisele Pelicot told the court in the southern city of Avignon, referring to her husband — one of 51 of her alleged abusers on trial — by only his surname. Speaking for the first time since the extraordinary trial began on Monday, Gisele Pelicot, now 71, revealed her emotion in almost 90 minutes of testimony, recounting her mysterious
AERIAL INCURSIONS: The incidents are a reminder that Russia’s aggressive actions go beyond Ukraine’s borders, Ukrainian Minister of Foreign Affairs Andrii Sybiha said Two NATO members on Sunday said that Russian drones violated their airspace, as one reportedly flew into Romania during nighttime attacks on neighboring Ukraine, while another crashed in eastern Latvia the previous day. A drone entered Romanian territory early on Sunday as Moscow struck “civilian targets and port infrastructure” across the Danube in Ukraine, the Romanian Ministry of National Defense said. It added that Bucharest had deployed F-16 warplanes to monitor its airspace and issued text alerts to residents of two eastern regions. It also said investigations were underway of a potential “impact zone” in an uninhabited area along the Romanian-Ukrainian border. There
RSS